Restore your patient’s RBCs and platelets in 6 minutes

With same^TM from i-SEP, ALL FOR PERFUSION offers a novel solution in the field of patient blood management for improved patient care.

Restore your patient’s RBCs and platelets in 6 minutes

42.2 % patients receive perioperative blood transfusions in cardiac surgical procedures² Allogenic transfusions save but:

• 60% are considered as inapropriate³
• 15-year longer life expectancy for non-transfused cardiac surgery patients¹
• Platelet transfusion is linked to many significant risks⁴

30 % patients not transfused due to blood shortage⁵

---

A new approach to your transfusion strategy

same^TM technology is recommended for hemorrhagic-risk surgery.

• Patented innovation
• Unique filtration technology
• Unprecendented platelet recovery
• Cycles aligned with surgical time: 6 min/500 mL⁶

---

Benefits & safety for patients⁷

• Improve patient blood management
• Save platelets, including for patients not transfused due to blood product shortage
• Reduce overall allogenic transfusion

---

Bestellinformationen

sameTM System	DS1000
Pre-assembled treatment kit	ST0501M1 (5 kits)
Suction & anticoagulation line	XJ-13-05 (24 pcs)
Blood collection reservoir	XJ-28-18 (6 pcs)
Vacuum line	LE0000M1 (30 pcs)
Reinfusion bag	BE1000M1 (25 pcs)
Waste bag	BW1000M1 (15 pcs)
Micro-aggregate chamber	LF0000M1 (25 pcs)

---

Download Flyer same^TM by i-SEP

---

1. WHO 2021, The urgent need of implementing patient blood management.
2. Perioperative transfusion and long-term mortality after cardiac surgery: a meta-analysis. Woldendorp K. et al. March 2023.
3. Appropriateness of Allogeneic Red Blood Cell Transfusion: The International Consensus Conference on Transfusion Outcomes. Shander A. et al. July 2011.
4. Platelet transfusion: Alloimmunization and refractoriness. Prodger CF. et al. April 2020.
5. EFS, French National Blood Bank Report, February 2022.
6. In-vitro study
7. Poster NATA April 2022